Cross-Platform Evaluation of a Tumor-Budding-Associated Gene Signature in Colorectal Cancer.
- 1Stamford University Bangladesh
Abstract
Spatial transcriptomics has identified AIF1, LIF, MRC1, and TNC as enriched in tumor budding (TB) regions of colorectal cancer. We investigated whether this TB associated gene module could be detected in bulk transcriptomic data. Pairwise gene co-occurrence was analyzed in bulk RNA-seq (TCGA-COADREAD, n=547) and single-cell RNA-seq (GSE178341, n=26,057 cells) using Fisher's exact tests with Benjamini-Hochberg correction. In bulk RNA-seq, pairwise fold-enrichments were weak (1.16 to 2.72), with AIF1 to LIF showing no significant association (FE=1.16, FDR=0.31). In single-cell data, the same pairs showed 31 to 184.5 fold enrichment (all FDR < 8e-38). Total UMI counts provided no evidence of doublet artifacts explaining these co-detection patterns. Exploratory enhancer-promoter interaction analysis in HCT116 cells further suggested these genes are controlled differently. GOT1 and MDH1, two malate-aspartate shuttle genes, showed lower expression in late-stage CRC (FDR less than or equal to 0.010). A bulk-derived risk score showed a modest association (Cox HR=1.21, p=0.021). Overall, TB-associated co-expression was more clearly detected at single-cell than bulk resolution, highlighting the importance of transcriptomic resolution when studying tumor-microenvironment-associated gene signatures.
Related
- 1099 TNF-α induced inflammatory signature in colorectal cancer inhibits NK cells through cancer associated fibroblast NECTIN2 signalling
- Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis
- Signature Definition Shapes Associations Between Exenatide-Related Transcriptional Programs and Macrophage Senescence Scores in Colorectal Cancer
- 1079 Development of a biologically aligned ex vivo TumorGraft3D platform to evaluate STC-1010-mediated immune priming and colorectal tumor killing
- Identification of Transcriptional Hippo Response Signature Connecting Inflammatory Bowel Disease and Colorectal Cancer Progression
BibTeX
@misc{sarkar2026crossplatform,
title = {{Cross-Platform Evaluation of a Tumor-Budding-Associated Gene Signature in Colorectal Cancer.}},
author = {P. Sarkar and P. Sarkar},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.09.757976},
url = {https://www.biorxiv.org/content/10.64898/2026.10.09.757976v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Cross-Platform Evaluation of a Tumor-Budding-Associated Gene Signature in Colorectal Cancer.
AU - P. Sarkar
AU - P. Sarkar
PY - 2026
DA - 2026/10/09
PB - bioRxiv
DO - 10.64898/2026.10.09.757976
UR - https://www.biorxiv.org/content/10.64898/2026.10.09.757976v1
AB - Spatial transcriptomics has identified AIF1, LIF, MRC1, and TNC as enriched in tumor budding (TB) regions of colorectal cancer. We investigated whether this TB associated gene module could be detected in bulk transcriptomic data. Pairwise gene co-occurrence was analyzed in bulk RNA-seq (TCGA-COADREAD, n=547) and single-cell RNA-seq (GSE178341, n=26,057 cells) using Fisher's exact tests with Benjamini-Hochberg correction. In bulk RNA-seq, pairwise fold-enrichments were weak (1.16 to 2.72), with AIF1 to LIF showing no significant association (FE=1.16, FDR=0.31). In single-cell data, the same pairs showed 31 to 184.5 fold enrichment (all FDR < 8e-38). Total UMI counts provided no evidence of doublet artifacts explaining these co-detection patterns. Exploratory enhancer-promoter interaction analysis in HCT116 cells further suggested these genes are controlled differently. GOT1 and MDH1, two malate-aspartate shuttle genes, showed lower expression in late-stage CRC (FDR less than or equal to 0.010). A bulk-derived risk score showed a modest association (Cox HR=1.21, p=0.021). Overall, TB-associated co-expression was more clearly detected at single-cell than bulk resolution, highlighting the importance of transcriptomic resolution when studying tumor-microenvironment-associated gene signatures.
ER -